Rift valley fever
MONDO:0017880Rift Valley fever (RVF), caused by the Rift Valley fever virus (RVFV), is an arbovirus characterized by a usually self-limiting febrile illness but that in some cases can also manifest with thrombosis, vision loss, hemorrhages and/or neurological symptoms.
Also known as: RVF
6 clinical trials for this condition and its sub-types, 3 tagged with Rift valley fever itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New vaccine against rift valley fever shows promise in early trial
Vaccine OngoingThis Phase 2 trial tests a new vaccine called ChAdOx1 RVF against Rift Valley fever in 240 healthy adults in Kenya. Participants receive either one or two doses of the vaccine or a rabies vaccine as a control. Researchers will check if the vaccine triggers a strong immune respons…
Phase 2 • Sponsor: University of Oxford • Aim: Vaccine
Last updated Jun 27, 2026 07:57 UTC
-
New drug combo IDB-011 tested for safety against rift valley fever
Prevention OngoingThis early-stage trial is testing the safety of a new drug combination called IDB-011 in 40 healthy adults. The goal is to see if it is safe and how the body processes it, as a first step toward possibly preventing Rift Valley Fever, a viral disease spread by mosquitoes. Particip…
Phase 1 • Sponsor: IDBiologics, Inc. • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC